Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi

Xuelian Xiong, Qiuyu Wang, Shuai Wang, Jinglong Zhang, Tongyu Liu, Liang Guo, Yonghao Yu, Jiandie D. Lin

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: Nonalcoholic steatohepatitis (NASH) is closely associated with metabolic syndrome and increases the risk for end-stage liver disease, such as cirrhosis and hepatocellular carcinoma. Despite this, the molecular events that influence NASH pathogenesis remain poorly understood. The objectives of the current study are to delineate the transcriptomic and proteomic signatures of NASH liver, to identify potential pathogenic pathways and factors, and to critically assess their role in NASH pathogenesis. Methods: We performed RNA sequencing and quantitative proteomic analyses on the livers from healthy and diet-induced NASH mice. We examined the association between plasma levels of TSK, a newly discovered hepatokine, and NASH pathologies and reversal in response to dietary switch in mice. Using TSK knockout mouse model, we determined how TSK deficiency modulates key aspects of NASH pathogenesis. Results: RNA sequencing and quantitative proteomic analyses revealed that diet-induced NASH triggers concordant reprogramming of the liver transcriptome and proteome in mice. NASH pathogenesis is linked to elevated plasma levels of the hepatokine TSK, whereas dietary switch reverses NASH pathologies and reduces circulating TSK concentrations. Finally, TSK inactivation protects mice from diet-induced NASH and liver transcriptome remodeling. Conclusions: Global transcriptomic and proteomic profiling of healthy and NASH livers revealed the molecular signatures of diet-induced NASH and dysregulation of the liver secretome. Our study illustrates a novel pathogenic mechanism through which elevated TSK in circulation promotes NASH pathologies, thereby revealing a potential target for therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)128-137
Number of pages10
JournalMolecular Metabolism
Volume20
DOIs
StatePublished - Feb 1 2019

Fingerprint

Diet
Proteomics
Liver
RNA Sequence Analysis
Pathology
Non-alcoholic Fatty Liver Disease
Transcriptome
End Stage Liver Disease
Proteome
Knockout Mice
Hepatocellular Carcinoma
Fibrosis

Keywords

  • Hepatokine
  • NAFLD
  • NASH
  • Proteomics
  • Secreted factor
  • Transcriptome
  • TSK
  • Type I interferon

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. / Xiong, Xuelian; Wang, Qiuyu; Wang, Shuai; Zhang, Jinglong; Liu, Tongyu; Guo, Liang; Yu, Yonghao; Lin, Jiandie D.

In: Molecular Metabolism, Vol. 20, 01.02.2019, p. 128-137.

Research output: Contribution to journalArticle

Xiong, Xuelian ; Wang, Qiuyu ; Wang, Shuai ; Zhang, Jinglong ; Liu, Tongyu ; Guo, Liang ; Yu, Yonghao ; Lin, Jiandie D. / Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. In: Molecular Metabolism. 2019 ; Vol. 20. pp. 128-137.
@article{3c7fa2fb722240f1aa02f4c6963ef39f,
title = "Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi",
abstract = "Objective: Nonalcoholic steatohepatitis (NASH) is closely associated with metabolic syndrome and increases the risk for end-stage liver disease, such as cirrhosis and hepatocellular carcinoma. Despite this, the molecular events that influence NASH pathogenesis remain poorly understood. The objectives of the current study are to delineate the transcriptomic and proteomic signatures of NASH liver, to identify potential pathogenic pathways and factors, and to critically assess their role in NASH pathogenesis. Methods: We performed RNA sequencing and quantitative proteomic analyses on the livers from healthy and diet-induced NASH mice. We examined the association between plasma levels of TSK, a newly discovered hepatokine, and NASH pathologies and reversal in response to dietary switch in mice. Using TSK knockout mouse model, we determined how TSK deficiency modulates key aspects of NASH pathogenesis. Results: RNA sequencing and quantitative proteomic analyses revealed that diet-induced NASH triggers concordant reprogramming of the liver transcriptome and proteome in mice. NASH pathogenesis is linked to elevated plasma levels of the hepatokine TSK, whereas dietary switch reverses NASH pathologies and reduces circulating TSK concentrations. Finally, TSK inactivation protects mice from diet-induced NASH and liver transcriptome remodeling. Conclusions: Global transcriptomic and proteomic profiling of healthy and NASH livers revealed the molecular signatures of diet-induced NASH and dysregulation of the liver secretome. Our study illustrates a novel pathogenic mechanism through which elevated TSK in circulation promotes NASH pathologies, thereby revealing a potential target for therapeutic intervention.",
keywords = "Hepatokine, NAFLD, NASH, Proteomics, Secreted factor, Transcriptome, TSK, Type I interferon",
author = "Xuelian Xiong and Qiuyu Wang and Shuai Wang and Jinglong Zhang and Tongyu Liu and Liang Guo and Yonghao Yu and Lin, {Jiandie D.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.molmet.2018.12.004",
language = "English (US)",
volume = "20",
pages = "128--137",
journal = "Molecular Metabolism",
issn = "2212-8778",
publisher = "Elsevier GmbH",

}

TY - JOUR

T1 - Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi

AU - Xiong, Xuelian

AU - Wang, Qiuyu

AU - Wang, Shuai

AU - Zhang, Jinglong

AU - Liu, Tongyu

AU - Guo, Liang

AU - Yu, Yonghao

AU - Lin, Jiandie D.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Objective: Nonalcoholic steatohepatitis (NASH) is closely associated with metabolic syndrome and increases the risk for end-stage liver disease, such as cirrhosis and hepatocellular carcinoma. Despite this, the molecular events that influence NASH pathogenesis remain poorly understood. The objectives of the current study are to delineate the transcriptomic and proteomic signatures of NASH liver, to identify potential pathogenic pathways and factors, and to critically assess their role in NASH pathogenesis. Methods: We performed RNA sequencing and quantitative proteomic analyses on the livers from healthy and diet-induced NASH mice. We examined the association between plasma levels of TSK, a newly discovered hepatokine, and NASH pathologies and reversal in response to dietary switch in mice. Using TSK knockout mouse model, we determined how TSK deficiency modulates key aspects of NASH pathogenesis. Results: RNA sequencing and quantitative proteomic analyses revealed that diet-induced NASH triggers concordant reprogramming of the liver transcriptome and proteome in mice. NASH pathogenesis is linked to elevated plasma levels of the hepatokine TSK, whereas dietary switch reverses NASH pathologies and reduces circulating TSK concentrations. Finally, TSK inactivation protects mice from diet-induced NASH and liver transcriptome remodeling. Conclusions: Global transcriptomic and proteomic profiling of healthy and NASH livers revealed the molecular signatures of diet-induced NASH and dysregulation of the liver secretome. Our study illustrates a novel pathogenic mechanism through which elevated TSK in circulation promotes NASH pathologies, thereby revealing a potential target for therapeutic intervention.

AB - Objective: Nonalcoholic steatohepatitis (NASH) is closely associated with metabolic syndrome and increases the risk for end-stage liver disease, such as cirrhosis and hepatocellular carcinoma. Despite this, the molecular events that influence NASH pathogenesis remain poorly understood. The objectives of the current study are to delineate the transcriptomic and proteomic signatures of NASH liver, to identify potential pathogenic pathways and factors, and to critically assess their role in NASH pathogenesis. Methods: We performed RNA sequencing and quantitative proteomic analyses on the livers from healthy and diet-induced NASH mice. We examined the association between plasma levels of TSK, a newly discovered hepatokine, and NASH pathologies and reversal in response to dietary switch in mice. Using TSK knockout mouse model, we determined how TSK deficiency modulates key aspects of NASH pathogenesis. Results: RNA sequencing and quantitative proteomic analyses revealed that diet-induced NASH triggers concordant reprogramming of the liver transcriptome and proteome in mice. NASH pathogenesis is linked to elevated plasma levels of the hepatokine TSK, whereas dietary switch reverses NASH pathologies and reduces circulating TSK concentrations. Finally, TSK inactivation protects mice from diet-induced NASH and liver transcriptome remodeling. Conclusions: Global transcriptomic and proteomic profiling of healthy and NASH livers revealed the molecular signatures of diet-induced NASH and dysregulation of the liver secretome. Our study illustrates a novel pathogenic mechanism through which elevated TSK in circulation promotes NASH pathologies, thereby revealing a potential target for therapeutic intervention.

KW - Hepatokine

KW - NAFLD

KW - NASH

KW - Proteomics

KW - Secreted factor

KW - Transcriptome

KW - TSK

KW - Type I interferon

UR - http://www.scopus.com/inward/record.url?scp=85059163543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059163543&partnerID=8YFLogxK

U2 - 10.1016/j.molmet.2018.12.004

DO - 10.1016/j.molmet.2018.12.004

M3 - Article

C2 - 30595550

AN - SCOPUS:85059163543

VL - 20

SP - 128

EP - 137

JO - Molecular Metabolism

JF - Molecular Metabolism

SN - 2212-8778

ER -